Join
Live feed
·
PRReleasevia Quantisnow
Innate Pharma S.A. ADS logo

Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress

ByQuantisnow·Wall Street's wire, on your screen.
IPHA· Innate Pharma S.A. ADS
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IPHA (Innate Pharma S.A. ADS) and more on Quantisnow.